What Is the Office of Inspector General (OIG)?

The Office of Inspector General (OIG) plays a central role in safeguarding Medicare and Medicaid by auditing payments, investigating fraud, and enforcing compliance across the healthcare system. For wound care providers, its oversight is especially significant in high-cost, documentation-intensive services where billing accuracy and medical necessity are under close scrutiny.

Key Takeaways

• The OIG oversees Medicare integrity through audits, investigations, and enforcement actions.
• High-cost and documentation-intensive services, including advanced wound therapies, are frequent areas of focus.
• Strong documentation and compliance practices are essential to reduce audit and enforcement risk.

The Office of Inspector General (OIG) within the U.S. Department of Health and Human Services (HHS) is an independent oversight body responsible for protecting the integrity of federal healthcare programs, including Medicare and Medicaid. Its mission includes combating fraud, waste, and abuse, as well as promoting efficiency and accountability across the healthcare system.¹

The OIG was established under the Inspector General Act of 1978, which authorizes it to conduct audits, investigations, and evaluations of federal programs and their participants.² In the Medicare context, the OIG serves as a key enforcement and oversight authority working alongside Centers for Medicare and Medicaid Services (CMS) and the Department of Justice.

Core Functions of the OIG

The OIG operates through several primary functions that directly affect healthcare providers:

1. Audits and Evaluations

The OIG conducts audits and program evaluations to assess whether Medicare payments are accurate and compliant with statutory and regulatory requirements. These reviews often focus on high-cost or rapidly growing services.

For example, OIG reports have examined Medicare Part B spending trends for certain categories of products and services, identifying billing vulnerabilities and areas of potential overutilization.³ Findings from these audits may lead to policy changes, provider education, or further enforcement activity.

2. Investigations

Through its Office of Investigations, the OIG investigates suspected fraud, including false billing, kickbacks, and other violations of federal law. These investigations may result in civil or criminal enforcement actions, often in collaboration with the Department of Justice.¹

3. Enforcement and Exclusions

The OIG has the authority to impose civil monetary penalties and exclude individuals or entities from participation in federal healthcare programs for certain violations, such as fraud or abuse.⁴ Exclusion effectively bars a provider from billing Medicare or Medicaid.

4. Guidance and Compliance Resources

The OIG publishes compliance guidance documents to help providers understand and meet federal requirements. These include recommendations on billing practices, documentation, and internal compliance programs.¹

The OIG and Medicare Program Integrity

The OIG is a central component of Medicare’s broader program integrity framework. While CMS administers coverage and payment, the OIG focuses on identifying and addressing vulnerabilities in how services are billed and reimbursed.

One of the OIG’s key tools is its Work Plan, which outlines areas of focus for audits and evaluations.⁵ Topics are updated regularly and often include services with:

• Rapid spending growth
• High utilization variability
• Known documentation challenges

These priorities frequently overlap with areas already identified through CMS data, such as improper payment measurements and claims analysis.

Why the OIG Matters in Wound Care

For wound care professionals, the OIG’s role is particularly relevant in the context of advanced therapies, including skin substitutes (often referred to as cellular and tissue-based products).

Several factors increase scrutiny in this area:

• High cost per episode of care
• Rapid growth in utilization in certain settings
• Complex documentation requirements tied to medical necessity

OIG reports have highlighted Medicare spending patterns and billing practices for these products, noting potential vulnerabilities related to documentation and utilization.³ While such reports do not establish fraud, they often identify areas where Medicare may be paying for services that do not meet coverage requirements.

In parallel, CMS data show that insufficient documentation is a leading cause of improper payments in Medicare Fee-for-Service.⁶ Because skin substitute use is documentation-intensive and longitudinal, it may be more susceptible to these findings if records do not fully support medical necessity.

The Relationship Between OIG and Other Agencies

The OIG does not operate in isolation. Its work intersects with:

• CMS: Implements coverage and payment policy
• Department of Justice (DOJ): Prosecutes fraud cases
• Medicare Administrative Contractors (MACs): Conduct medical review and education

OIG findings often inform CMS policy updates, MAC education initiatives, and, in some cases, targeted enforcement actions.

Practical Implications for Providers

For wound care teams, the OIG’s role translates into several practical priorities:

• Accurate documentation: Ensure that records support medical necessity, including wound characteristics, prior care, and response to treatment.
• Compliance awareness: Stay informed about OIG Work Plan topics and audit trends.
• Billing integrity: Align coding and billing practices with CMS and MAC requirements.
• Internal controls: Maintain compliance programs that identify and address potential risks.

These steps are essential not only for avoiding audits but also for demonstrating adherence to Medicare’s statutory standards.

The Bottom Line

The Office of Inspector General (OIG) serves as Medicare’s watchdog, identifying risks, auditing payments, and enforcing compliance across the healthcare system. For wound care professionals, its oversight is especially relevant in areas involving high-cost, documentation-intensive therapies. Understanding the OIG’s role helps providers align clinical practice with regulatory expectations and maintain compliant participation in the Medicare program.

References

1. Office of Inspector General, U.S. Department of Health and Human Services. About OIG. Accessed April 13, 2026. https://oig.hhs.gov/about-oig/.

2. United States Code. Inspector General Act of 1978. Accessed. April 13, 2026. https://www.govinfo.gov/content/pkg/USCODE-2011-title5/html/USCODE-2011-title5-app-inspector.htm.

3. Office of Inspector General, U.S. Department of Health and Human Services. Medicare Part B Payment Trends for Skin Substitutes Raise Major Concerns About Fraud, Waste, and Abuse. OEI Reports. Accessed April 13, 2026. https://oig.hhs.gov/reports/all/2025/medicare-part-b-payment-trends-for-skin-substitutes-raise-major-concerns-about-fraud-waste-and-abuse/.

4. Social Security Administration. Social Security Act Section 1862. Accessed April 13, 2026. https://www.ssa.gov/OP_Home/ssact/title18/1862.htm.

5. Office of Inspector General, U.S. Department of Health and Human Services. Work Plan. Accessed April 15, 2026. https://oig.hhs.gov/reports/work-plan/.

6. Centers for Medicare & Medicaid Services. 2023 Medicare Fee-for-Service Supplemental Improper Payment Data. Accessed April 13, 2026. https://www.cms.gov/data-research/monitoring-programs/improper-payment-measurement-programs/comprehensive-error-rate-testing-cert/cert-reports/2025-medicare-fee-service-supplemental-improper-payment-data-2.